Abstract
Cardiostimulant effects of the non‐conventional partial agonist, CGP 12177A, are mediated by a receptor distinct from the β3‐adrenoceptor and termed the putative β4‐adrenoceptor. Using a rat model of cardiac failure, induced by myocardial infarction (MI), we compared the desensitization and resensitization of responses to CGP 12177A with those to isoprenaline and RO 363 in left (LA) and right atria (RA). We also examined the ability of β‐adrenoceptor antagonists to block responses to CGP 12177A. MI reduced the maximum inotropic response to isoprenaline by 48% (sham 4.1±0.6 mN, n=10; MI 2.1±0.4 mN, n=8, Pn=10; MI 1.8±0.3 mN, n=8, Pn=5; MI 0.7±0.2 mN, n=7, P50: sham 8.79±0.08, n=10; MI 8.30±0.10, n=8; P=0.001) and RO 363 (pEC50: sham 8.69±0.07, n=10; MI 8.33±0.10, n=8; P−1, i.p.) restored the maximum inotropic response and sensitivity to isoprenaline (sham 3.5±0.5 mN, n=9; MI 3.2±0.6 mN, n=11, P=0.702) and CGP 12177A (sham 1.6±0.3 mN, n=6; MI 1.9±0.4 mN, n=7, P=0.537) in MI animals to levels similar to those in the sham group. CGP 20712A (pKB: LA 6.7±0.2, n=6; RA 7.1±0.1, n=4), ICI 118,551 (pKB: LA 6.4±0.1, n=5; RA 6.3±0.1, n=6), propranolol (pKB: LA 6.6±0.1, n=5; RA 6.8±0.1, n=6) and bupranolol (pKB: LA 7.2±0.1, n=6; RA 7.7±0.1, n=8), showed moderate affinity for the putative β4‐adrenoceptor. Desensitization after MI and resensitization (after pertussis toxin treatment) to isoprenaline and CGP 12177A therefore occur in parallel, suggesting that the β1‐ and putative β4‐adrenoceptor use the same signalling pathway. Antagonist affinity studies confirmed that drugs acting at β1‐adrenoceptors also interact with putative β4‐adrenoceptors with approximately 100 times lower affinity. We suggest that CGP 12177A produces its cardiac effects by interacting with a low affinity state of the β1‐adrenoceptor. British Journal of Pharmacology (1999) 128, 1399–1406; doi:10.1038/sj.bjp.0702920